20-HETE induces hyperglycemia through the cAMP/ PKA-PhK-GP pathway

Molecular Endocrinology

Volumn 26, Issue 11, 2012, Pages 1907-1916

  Lai, Guangrui ^a   Wu, Jingjing ^a   Liu, Xiaoliang ^a   Zhao, Yanyan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOCHROME P450; CYTOCHROME P450 4F2; GLUCOSE; GLUCOSE TRANSPORTER; GLYCOGEN PHOSPHORYLASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LIVER ENZYME; PHOSPHORYLASE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; LIVER MICROSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET ORGAN; TRANSGENIC MOUSE; VALIDATION PROCESS; WILD TYPE;

AMIDINES; ANIMALS; BLOOD GLUCOSE; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOCHROME P-450 ENZYME SYSTEM; GLUCOSE TRANSPORTER TYPE 1; GLYCOGEN PHOSPHORYLASE; HYDROXYEICOSATETRAENOIC ACIDS; HYPERGLYCEMIA; HYPERTENSION; INSULIN RECEPTOR SUBSTRATE PROTEINS; ISOQUINOLINES; LIVER; MALE; MICE; MICE, TRANSGENIC; PHOSPHORYLASE KINASE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SULFONAMIDES;

MUS; MUS MUSCULUS;

EID: 84868104723     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1139     Document Type: Article

References (36)

1. Long AN, Dagogo-Jack S 2011 Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich) 13:244-251
2. Bianchi C, Miccoli R, Penno G, Del Prato S 2008 Primary prevention of cardiovascular disease in people with dysglycemia. Diabetes Care 31:S 208-S 214
3. Reaven GM 2011 Relationships among insulin resistance, type 2 diabetes, essential hypertension, and cardiovascular disease: similarities and differences. J Clin Hypertens (Greenwich) 13:238-243
4. Di Filippo C, Verza M, Coppola L, Rossi F, D'Amico M, Marfella R 2007 Insulin resistance and postprandial hyperglycemia the bad companions in natural history of diabetes: effects on health of vascular tree. Curr Diabetes Rev 3:268-273
5. Williams JM, Murphy S, Burke M, Roman RJ 2010 20-Hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. J Cardiovasc Pharmacol 56:336-344
6. Inoue K, Sodhi K, Puri N, Gotlinger KH, Cao J, Rezzani R, Falck JR, Abraham NG, Laniado-Schwartzman M 2009 Endothelial-specific CYP 4A 2 overexpression leads to renal injury and hypertension via increased production of 20-HETE. Am J Physiol Renal Physiol 297:F 875-F 884
7. Quigley R, Baum M, Reddy KM, Griener JC, Falck JR 2000 Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport. Am J Physiol Renal Physiol 278:F 949-F 953
8. Otani L, Ninomiya T, Murakami M, Osajima K, Kato H, Murakami T 2009 Sardine peptide with angiotensin I-converting enzyme inhibitory activity improves glucose tolerance in stroke-prone spontaneously hypertensive rats. Biosci Biotechnol Biochem 73: 2203-2209
9. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, Montagnani M 2005 Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 289:H 813-H 822
10. Li R, Zhang H, Wang W, Wang X, Huang Y, Huang C, Gao F 2010 Vascular insulin resistance in prehypertensive rats: role of PI 3-kinase/ Akt/eNOS signaling. Eur J Pharmacol 628:140-147
11. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE 2009 Mechanisms of podocyte injury in diabetes: role of cytochrome P 450 and NADPH oxidases. Diabetes 58:1201-1211
12. Yousif MH, Benter IF, Dunn KM, Dahly-Vernon AJ, Akhtar S, Roman RJ 2009 Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes. Auton Autacoid Pharmacol 29: 1-12
13. Chen YJ, Li J, Quilley J 2008 Deficient renal 20-HETE release in the diabetic rat is not the result of oxidative stress. Am J Physiol Heart Circ Physiol 294:H 2305-H 2312
14. Luo P, Zhou Y, Chang HH, Zhang J, Seki T, Wang CY, Inscho EW, Wang MH 2009 Glomerular 20-HETE, EETs, and TGF-α1 in diabetic nephropathy. Am J Physiol Renal Physiol 296:F 556-F 563
15. Tsai IJ, Croft KD, Mori TA, Falck JR, Beilin LJ, Puddey IB, Barden AE 2009 20-HETE and F 2-isoprostanes in the metabolic syndrome: the effect of weight reduction. Free Radic Biol Med 46:263-270
16. Lasker JM, Chen WB, Wolf I, Bloswick BP, Wilson PD, Powell PK 2000 Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of CYP 4F 2 and CYP 4A 11. J Biol Chem 275:4118-4126
17. Liu H, Zhao Y, Nie D, Shi J, Fu L, Li Y, Yu D, Lu J 2008 Association of a functional cytochrome P 4504F 2 haplotype with urinary 20-HETE and hypertension. J Am Soc Nephrol 19:714-721
18. Liu X, Zhao Y, Wang L, Yang X, Zheng Z, Zhang Y, Chen F, Liu H 2009 Overexpression of cytochrome P 450 4F 2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure. Kidney Int 75:1288-1296
19. Lai G, Liu X, Wu J, Liu H, Zhao Y 2012 Evaluation of CMV and KAP promoters for driving the expression of human CYP 4F 2 in transgenic mice. Int J Mol Med 29:107-112
20. Somsák L, Czifrák K, Tóth M, Bokor E, Chrysina ED, Alexacou KM, Hayes JM, Tiraidis C, Lazoura E, Leonidas DD, Zographos SE, Oikonomakos NG 2008 New inhibitors of glycogen phosphorylase as potential antidiabetic agents. Curr Med Chem 15:2933-2983
21. Buchbinder JL, Luong CB, Browner MF, Fletterick RJ 1997 Partial activation of muscle phosphorylase by replacement of serine 14 with acidic residues at the site of regulatory phosphorylation. Biochemistry 36:8039-8044
22. Waraich RS, Weigert C, Kalbacher H, Hennige AM, Lutz SZ, Häring HU, Schleicher ED, Voelter W, Lehmann R 2008 Phosphorylation of Ser357 of rat insulin receptor substrate-1 mediates adverse effects of protein kinase C-δ on insulin action in skeletal muscle cells. J Biol Chem 283:11226-11233
23. Gual P, Le Marchand-Brustel Y, Tanti JF 2005 Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99-109
24. Bryant NJ, Govers R, James DE 2002 Regulated transport of the glucose transporter GLUT 4. Nat Rev Mol Cell Biol 3:267-277
25. Andreeva IE, Rice NA, CarlsonGM 2002 The regulatory α subunit of phosphorylase kinase may directly participate in the binding of glycogen phosphorylase. Biochemistry (Mosc) 67:1197-1202
26. Sun CW, Falck JR, Harder DR, Roman RJ 1999 Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33:414-418
27. Obara K, Koide M, Nakayama K 2002 20-Hydroxyeicosatetraenoic acid potentiates stretch-induced contraction of canine basilar artery via PKC alpha-mediated inhibition of KCa channel. Br J Pharmacol 137:1362-1370
28. Pratt PF, Falck JR, Reddy KM, Kurian JB, Campbell WB 1998 20-HETE relaxes bovine coronary arteries through the release of prostacyclin. Hypertension 31:237-241
29. Miyata N, Roman RJ 2005 Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 41:175-193
30. Oyekan AO 2005 Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the rat. J Pharmacol Exp Ther 313:1289-1295
31. Jenssen T, Nurjhan N, Consoli A, Gerich JE 1990 Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 86:489-497
32. Puhakainen I, Koivisto VA, Yki-Järvinen H 1991 No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 40:1319-1327
33. Martin WH, Hoover DJ, Armento SJ, Stock IA, McPherson RK, Danley DE, Stevenson RW, Barrett EJ, Treadway JL 1998 Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo. Proc Natl Acad Sci USA 95:1776-1781
34. Fosgerau K, Mittelman SD, Sunehag A, Dea MK, Lundgren K, Bergman RN 2001 Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model. Am J Physiol Endocrinol Metab 281:E 375-E 383
35. Adochio RL, Leitner JW, Gray K, Draznin B, Cornier MA 2009 Early responses of insulin signaling to high-carbohydrate and highfat overfeeding. Nutr Metab (Lond) 6:37
36. Laffer CL, Laniado-Schwartzman M, Nasjletti A, Elijovich F 2004 20-HETE and circulating insulin in essential hypertension with obesity. Hypertension 43:388-392